IM Cannabis Achieves C$4.7M Positive Operating Cash Flow, C$54.7M Revenue, Fueled by 134%+ Germany Growth
IMCC sits 36% above its 52-week low of $0.304.
Summary
IM Cannabis Corp. reported strong 2025 financial results, achieving a significant operational milestone with C$4.7 million in positive operating cash flow, a substantial turnaround from negative cash flow in 2024. The company posted C$54.7 million in total revenue, driven by robust growth in Germany, where revenue surged over 134% to C$36.3 million, now comprising over 66% of total group revenue. This positive cash flow and strong German performance are critical for a company of this size, indicating improved financial health and successful execution in a key market. While the company recently announced a non-binding agreement to acquire a 51% stake in Blackaxe Technologies for diversification, this earnings report provides a clear view of its core cannabis operations. Investors will be watching for sustained positive cash flow, continued growth in Germany, and further details on the integration and strategic impact of the Blackaxe acquisition.
At the time of this announcement, IMCC was trading at $0.41 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.1M. The 52-week trading range was $0.30 to $7.12. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.